Published in Lancet on April 10, 1982
Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ (1983) 4.81
Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog (2009) 4.56
Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems. J Virol (1999) 4.32
Studies of reservoir hosts for Marburg virus. Emerg Infect Dis (2007) 3.35
Mapping the zoonotic niche of Ebola virus disease in Africa. Elife (2014) 2.97
Ecologic and geographic distribution of filovirus disease. Emerg Infect Dis (2004) 2.97
Evaluation of perceived threat differences posed by filovirus variants. Biosecur Bioterror (2011) 2.62
Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. Int J Exp Pathol (1995) 2.56
Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus. J Virol (2009) 2.41
Clinical manifestations and case management of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008. PLoS One (2012) 2.33
Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses. Vaccine (2008) 2.33
Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J Virol (1996) 2.26
Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo. Emerg Infect Dis (2003) 2.22
Response to imported case of Marburg hemorrhagic fever, the Netherland. Emerg Infect Dis (2009) 2.07
Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS Pathog (2012) 2.00
Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine. J Virol (2006) 1.85
Marburg virus gene 4 encodes the virion membrane protein, a type I transmembrane glycoprotein. J Virol (1993) 1.85
Filoviruses in bats: current knowledge and future directions. Viruses (2014) 1.79
Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections. Clin Vaccine Immunol (2008) 1.78
Undiagnosed acute viral febrile illnesses, Sierra Leone. Emerg Infect Dis (2014) 1.72
VP40, the matrix protein of Marburg virus, is associated with membranes of the late endosomal compartment. J Virol (2002) 1.63
VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice. Antimicrob Agents Chemother (2006) 1.63
Replication of Marburg virus in human endothelial cells. A possible mechanism for the development of viral hemorrhagic disease. J Clin Invest (1993) 1.57
The use of a mobile laboratory unit in support of patient management and epidemiological surveillance during the 2005 Marburg Outbreak in Angola. PLoS Negl Trop Dis (2011) 1.53
Ebola and Marburg hemorrhagic fevers: neglected tropical diseases? PLoS Negl Trop Dis (2012) 1.51
Multivesicular bodies as a platform for formation of the Marburg virus envelope. J Virol (2004) 1.47
The matrix protein of Marburg virus is transported to the plasma membrane along cellular membranes: exploiting the retrograde late endosomal pathway. J Virol (2004) 1.43
Forty-five years of Marburg virus research. Viruses (2012) 1.34
Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names. Viruses (2014) 1.33
Interferon-β therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever. J Infect Dis (2012) 1.27
Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins. Clin Vaccine Immunol (2006) 1.26
Clinical management of filovirus-infected patients. Viruses (2012) 1.26
Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway. Proc Natl Acad Sci U S A (2008) 1.21
Virological and serological findings in Rousettus aegyptiacus experimentally inoculated with vero cells-adapted hogan strain of Marburg virus. PLoS One (2012) 1.15
Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA. Sci Transl Med (2014) 1.12
Clinical aspects of Marburg hemorrhagic fever. Future Virol (2011) 1.06
Sorting of Marburg virus surface protein and virus release take place at opposite surfaces of infected polarized epithelial cells. J Virol (2001) 1.05
Nosocomial spread of viral disease. Clin Microbiol Rev (2001) 1.05
Mechanism of human antibody-mediated neutralization of Marburg virus. Cell (2015) 1.04
Antibody-dependent enhancement of Marburg virus infection. J Infect Dis (2011) 1.02
Persistence of Ebola virus in various body fluids during convalescence: evidence and implications for disease transmission and control. Epidemiol Infect (2016) 1.02
Marburg virus in fruit bat, Kenya. Emerg Infect Dis (2010) 1.00
Different potential of C-type lectin-mediated entry between Marburg virus strains. J Virol (2010) 0.98
Mapping the zoonotic niche of Marburg virus disease in Africa. Trans R Soc Trop Med Hyg (2015) 0.96
The marburg virus 3' noncoding region structurally and functionally differs from that of ebola virus. J Virol (2009) 0.96
Development and evaluation of a simple assay for Marburg virus detection using a reverse transcription-loop-mediated isothermal amplification method. J Clin Microbiol (2010) 0.95
AIDS: an old disease from Africa? Br Med J (Clin Res Ed) (1984) 0.94
Factors associated with Marburg hemorrhagic fever: analysis of patient data from Uige, Angola. J Infect Dis (2010) 0.91
Ebola virus disease and Marburg disease in pregnancy: a review and management considerations for filovirus infection. Obstet Gynecol (2015) 0.89
Phylogenetic assessment of filoviruses: how many lineages of Marburg virus? Ecol Evol (2012) 0.89
"Filoviruses": a real pandemic threat? EMBO Mol Med (2009) 0.88
Durability of a vesicular stomatitis virus-based marburg virus vaccine in nonhuman primates. PLoS One (2014) 0.88
Transmission potential and design of adequate control measures for Marburg hemorrhagic fever. PLoS One (2012) 0.86
Comparison of the Pathogenesis of the Angola and Ravn Strains of Marburg Virus in the Outbred Guinea Pig Model. J Infect Dis (2015) 0.83
Dose Response of MARV/Angola Infection in Cynomolgus Macaques following IM or Aerosol Exposure. PLoS One (2015) 0.82
The Baboon (Papio spp.) as a model of human Ebola virus infection. Viruses (2012) 0.82
Emerging and re-emerging viruses: A global challenge illustrated by Chikungunya virus outbreaks. World J Virol (2012) 0.81
Effectiveness of Personal Protective Equipment for Healthcare Workers Caring for Patients with Filovirus Disease: A Rapid Review. PLoS One (2015) 0.80
Potential for introduction of bat-borne zoonotic viruses into the EU: a review. Viruses (2014) 0.80
Guidance for contact tracing of cases of Lassa fever, Ebola or Marburg haemorrhagic fever on an airplane: results of a European expert consultation. BMC Public Health (2012) 0.79
Ebola: Hidden reservoirs. Nature (2015) 0.79
Ebola virus transmission. Int J Exp Pathol (1995) 0.79
Neglected filoviruses. FEMS Microbiol Rev (2016) 0.78
How severe and prevalent are Ebola and Marburg viruses? A systematic review and meta-analysis of the case fatality rates and seroprevalence. BMC Infect Dis (2016) 0.76
Calculation of incubation period and serial interval from multiple outbreaks of Marburg virus disease. BMC Res Notes (2014) 0.76
[Bats and other reservoir hosts of Filoviridae. Danger of epidemic on the African continent?--a deductive literature analysis]. Wien Klin Wochenschr (2010) 0.76
A Multiplex PCR/LDR Assay for the Simultaneous Identification of Category A Infectious Pathogens: Agents of Viral Hemorrhagic Fever and Variola Virus. PLoS One (2015) 0.75
Delayed Time-to-Treatment of an Antisense Morpholino Oligomer Is Effective against Lethal Marburg Virus Infection in Cynomolgus Macaques. PLoS Negl Trop Dis (2016) 0.75
Modelling filovirus maintenance in nature by experimental transmission of Marburg virus between Egyptian rousette bats. Nat Commun (2017) 0.75
A systematic review and meta-analysis of seroprevalence surveys of ebolavirus infection. Sci Data (2017) 0.75
Ebola virus disease and pregnancy: A review of the current knowledge of Ebola virus pathogenesis, maternal, and neonatal outcomes. Birth Defects Res (2017) 0.75
Virus-Like Particle Vaccination Protects Nonhuman Primates from Lethal Aerosol Exposure with Marburgvirus (VLP Vaccination Protects Macaques against Aerosol Challenges). Viruses (2016) 0.75
Natural History of Aerosol Exposure with Marburg Virus in Rhesus Macaques. Viruses (2016) 0.75
Ecological Niche Modeling for Filoviruses: A Risk Map for Ebola and Marburg Virus Disease Outbreaks in Uganda. PLoS Curr (2017) 0.75
Filoviruses and bats. (2017) 0.75
In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol (1988) 12.52
Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature (1985) 12.08
Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol (1999) 11.77
Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell (1987) 11.56
Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell (1987) 11.15
Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire. Lancet (1977) 9.23
Human serum activities against Hemophilus influenzae, type b. J Clin Invest (1972) 7.85
Lassa fever. Effective therapy with ribavirin. N Engl J Med (1986) 6.38
A rapid chemical assay for gentamicin. N Engl J Med (1972) 6.36
Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene. Nature (1983) 5.90
Outer membrane protein composition in disease isolates of Haemophilus influenzae: pathogenic and epidemiological implications. Infect Immun (1980) 5.68
Comparison of phenotypic and genotypic techniques for identification of unusual aerobic pathogenic gram-negative bacilli. J Clin Microbiol (1998) 5.27
A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis (1987) 5.27
Transferable R factors in enteric bacteria causing infection of the genitourinary tract. Lancet (1966) 5.01
Isolation of the etiologic agent of Korean Hemorrhagic fever. J Infect Dis (1978) 4.95
Haemophilus influenzae meningitis in infant rats after intranasal inoculation. J Infect Dis (1974) 4.94
Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation. Infect Immun (1973) 4.80
R factors mediate resistance to mercury, nickel, and cobalt. Science (1967) 4.57
Expression of active human factor VIII from recombinant DNA clones. Nature (1984) 4.36
A plaque neutralization method for arboviruses. Proc Soc Exp Biol Med (1967) 4.27
Identification and nucleotide sequence of a human locus homologous to the v-myc oncogene of avian myelocytomatosis virus MC29. Nature (1983) 4.06
The child PTSD Symptom Scale: a preliminary examination of its psychometric properties. J Clin Child Psychol (2001) 4.00
Cloning, nucleotide sequence, and expression in Escherichia coli of the exotoxin A structural gene of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (1984) 3.98
Brain responses to micro-machined silicon devices. Brain Res (2003) 3.75
A discrete element 3' of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans activator. Mol Cell Biol (1988) 3.74
A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis (1987) 3.51
Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b. Pediatrics (1973) 3.33
Improved enzymatic assay of chloramphenicol. Clin Chem (1978) 3.31
Hemorrhagic fevers of Southeast Asia and South America: a comparative appraisal. Prog Med Virol (1967) 3.22
Primary structure and biochemical properties of an M2 muscarinic receptor. Science (1987) 3.16
Mode of action of novobiocin in Escherichia coli. J Bacteriol (1967) 3.09
Rapid diagnosis of Hemophilus influenzae type b infections by latex particle agglutination and counterimmunoelectrophoresis. J Pediatr (1978) 3.05
Measurement of antibodies to Machupo virus by the indirect fluorescent technique. Proc Soc Exp Biol Med (1973) 2.97
The toxicologic and pharmacologic properties of amantadine hydrochloride. Toxicol Appl Pharmacol (1969) 2.95
Clinical virology of Lassa fever in hospitalized patients. J Infect Dis (1987) 2.94
Antigenic variants of Venezuelan equine encephalitis virus: their geographic distribution and epidemiologic significance. Am J Epidemiol (1969) 2.91
Identification of coryneform bacterial isolates by ribosomal DNA sequence analysis. J Clin Microbiol (2000) 2.87
Do pili play a role in pathogenicity of Haemophilus influenzae type B? Lancet (1982) 2.84
Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b. J Clin Invest (1972) 2.81
Hemophilus influenzae type B susceptibility to 17 antibiotics. J Pediatr (1975) 2.74
Nucleotide sequence to the v-myc oncogene of avian retrovirus MC29. Proc Natl Acad Sci U S A (1983) 2.66
Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya. Arch Virol Suppl (1996) 2.63
A multicenter clinical trial of oral ribavirin in HIV-infected patients with lymphadenopathy. The Ribavirin-LAS Collaborative Group. J Acquir Immune Defic Syndr (1990) 2.57
Dissolved organic matter and heterotrophic microneuston in the surface microlayers of the north atlantic. Science (1976) 2.54
Circulating polyribophosphate in Hemophilus influenzae, type b meningitis. Correlation with clinical course and antibody response. J Clin Invest (1975) 2.48
Gentamicin:adenine mononucleotide transferase: partial purification, characterization, and use in the clinical quantitation of gentamicin. J Infect Dis (1974) 2.45
Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation. J Clin Microbiol (1982) 2.44
The costs of treating COPD in the United States. Chest (2001) 2.43
Isolation of Hantaan virus, the etiologic agent of Korean hemorrhagic fever, from wild urban rats. J Infect Dis (1982) 2.42
Phenotypic and genetic variation in the susceptibility of Haemophilus influenzae type b to antibodies to somatic antigens. J Clin Invest (1980) 2.42
Selective vulnerability of dentate hilar neurons following traumatic brain injury: a potential mechanistic link between head trauma and disorders of the hippocampus. J Neurosci (1992) 2.41
Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. EMBO J (1987) 2.39
Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. J Infect Dis (1980) 2.38
Cerebral astrocyte response to micromachined silicon implants. Exp Neurol (1999) 2.37
Countercurrent immunoelectrophoresis in the diagnosis of systemic diseases caused by Hemophilus infleunzae type b. J Pediatr (1972) 2.33
Role of heat-labile toxigenic Escherichia coli and Reovirus-like agent in diarrhoea in Boston children. Lancet (1975) 2.31
Ebola hemorrhagic fever: Tandala, Zaire, 1977-1978. J Infect Dis (1980) 2.30
Studies on the epidemiology of resistance (R) factors. I. Analysis of Klebsiella isolates in a general hospital. II. A prospective study of R factor transfer in the host. Ann Intern Med (1969) 2.28
Traumatic axonal injury induces calcium influx modulated by tetrodotoxin-sensitive sodium channels. J Neurosci (2001) 2.28
Recovery of resistance (R) factors from a drug-free community. Lancet (1969) 2.26
Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Proc Natl Acad Sci U S A (1991) 2.24
Isolation and partial characterization of outer and inner membranes from encapsulated Haemophilus influenzae type b. J Bacteriol (1981) 2.21
The human growth hormone locus: nucleotide sequence, biology, and evolution. Genomics (1989) 2.17
Pathologic and virologic study of fatal Lassa fever in man. Am J Pathol (1982) 2.14
The reliability of quantitative electroencephalography as an indicator of cerebral ischemia. Anesth Analg (1995) 2.12
Venezuelan equine encephalitis. Adv Vet Sci Comp Med (1974) 2.12
The cost-effectiveness of screening for oral cancer in primary care. Health Technol Assess (2006) 2.04
Comparison of protein A gene sequencing with pulsed-field gel electrophoresis and epidemiologic data for molecular typing of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2000) 2.03
The role of encapsulation and host age in the clearance of Haemophilus influenzae bacteremia. J Infect Dis (1977) 2.01
Immune tolerance in Calomys callosus infected with Machupo virus. Nature (1969) 2.00
A health week in rural general practice. Br Med J (1967) 1.99
Measuring appropriate use of acute beds. A systematic review of methods and results. Health Policy (2000) 1.97
An inhibitor of indoleacetic acid oxidase from pea tips. Plant Physiol (1961) 1.97
Biologic differences between strains of Ebola virus from Zaire and Sudan. J Infect Dis (1983) 1.94
The paradox of Hemophilus infuenzae type B bacteremia in the presence of serum bactericidal activity. J Clin Invest (1976) 1.94
Arenoviruses in Vero cells: ultrastructural studies. J Virol (1970) 1.91
Filoviridae: a taxonomic home for Marburg and Ebola viruses? Intervirology (1982) 1.89
Who should practise? Where? CMAJ (1994) 1.87
Human antibody response to individual outer membrane proteins of Haemophilus influenzae type b. Infect Immun (1982) 1.83
Morphological comparison of Machupo with lymphocytic choriomeningitis virus: basis for a new taxonomic group. J Virol (1969) 1.82
The measurement of specific antibodies in Bolivian hemorrhagic fever by neutralization of virus plaques. Proc Soc Exp Biol Med (1969) 1.82
Arenoviruses: proposed name for a newly defined virus group. J Virol (1970) 1.81
Immunoglobulin M and G responses measured by immunofluorescence in patients with Lassa or Marburg virus infections. Bull World Health Organ (1979) 1.80
Resistance factor-mediated streptomycin resistance. J Bacteriol (1969) 1.78
The MHC-binding and gp120-binding functions of CD4 are separable. Science (1989) 1.77
Characterization of R factor beta-lactamases by the acidimetric method. Antimicrob Agents Chemother (1973) 1.76
Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity. Proc Natl Acad Sci U S A (1991) 1.76
Serum gamma-glutamyltransferase and alkaline phosphatase in rheumatoid arthritis. J Clin Pathol (1982) 1.74
Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions. Am J Cardiol (1996) 1.69
Headache in mild-to-moderate hypertension and its reduction by irbesartan therapy. Arch Intern Med (2000) 1.68
Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice. Nat Genet (1997) 1.67
R factor infection of Escherichia coli lyophilized in 1946. J Bacteriol (1967) 1.66
Role of immunity in the clearance of bacteremia due to Haemophilus influenzae. J Infect Dis (1978) 1.65
Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate. Trans R Soc Trop Med Hyg (1988) 1.65
Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer (1998) 1.61
Enduring cognitive, neurobehavioral and histopathological changes persist for up to one year following severe experimental brain injury in rats. Neuroscience (1998) 1.60
Characterization of human antibody to polyribophosphate, the capsular antigen of Hemophilus influenzae, type B. Clin Immunol Immunopathol (1973) 1.60
Intraocular use of rituximab. Eye (Lond) (2007) 1.58
Biomechanical analysis of experimental diffuse axonal injury. J Neurotrauma (1995) 1.57
Ebola virus: identification of virion structural proteins. J Gen Virol (1980) 1.54